The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to assess neuroimaging markers that have previously been shown to be involved in chronic pain.
Arthritis, Rheumatoid, Pain
The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to assess neuroimaging markers that have previously been shown to be involved in chronic pain.
Chronic Pain in Rheumatoid Arthritis
-
University of Colorado, Denver, Colorado, United States, 80045
Northwestern University, Chicago, Illinois, United States, 60611
Johns Hopkins University, Baltimore, Maryland, United States, 21224
University of Michigan, Ann Arbor, Michigan, United States, 48019
Hospital for Special Surgery, New York, New York, United States, 10021
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Northwestern University,
Yvonne C Lee, MD, MMSc, PRINCIPAL_INVESTIGATOR, Northwestern University
2026-04-12